HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ji-Cheng Li Selected Research

Yin Deficiency (Yinxu)

1/2020Review on the systems biology research of Yin-deficiency-heat syndrome in traditional Chinese medicine.
1/2020Study on potential biomarkers of energy metabolism-related to early-stage Yin-deficiency-heat syndrome based on metabolomics and transcriptomics.
1/2020Screening of potential biomarkers for Yin-deficiency-heat syndrome based on UHPLC-MS method and the mechanism of Zhibai Dihuang granule therapeutic effect.
1/2020A group of serum proteins as potential diagnostic biomarkers for Yin-deficiency-heat syndrome.
10/2018The Chinese herbal formula Zhibai Dihuang Granule treat Yin-deficiency-heat syndrome rats by regulating the immune responses.
1/2018iTRAQ-based proteomic analysis to identify the molecular mechanism of Zhibai Dihuang Granule in the Yin-deficiency-heat syndrome rats.
9/2014Screening and identification of potential biomarkers and establishment of the diagnostic serum proteomic model for the Traditional Chinese Medicine Syndromes of tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ji-Cheng Li Research Topics

Disease

24Pulmonary Tuberculosis
01/2022 - 06/2010
16Neoplasms (Cancer)
11/2021 - 10/2004
13Tuberculosis (Tuberculoses)
01/2021 - 06/2010
7Yin Deficiency (Yinxu)
01/2020 - 09/2014
5Lymphatic Metastasis
03/2009 - 10/2004
4Pneumonia (Pneumonitis)
01/2022 - 01/2013
4Hepatocellular Carcinoma (Hepatoma)
10/2014 - 01/2010
4Carcinoma (Carcinomatosis)
12/2010 - 07/2006
3Lung Neoplasms (Lung Cancer)
01/2022 - 01/2013
3Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
11/2020 - 01/2016
2COVID-19
01/2022 - 11/2021
2Nasopharyngeal Carcinoma
01/2022 - 01/2021
2Myocardial Infarction
01/2022 - 05/2021
2Microsatellite Instability
01/2020 - 12/2010
2Chronic Obstructive Pulmonary Disease (COPD)
01/2017 - 01/2013
2Lung Diseases (Lung Disease)
01/2015 - 10/2011
2Hemorrhagic Shock
10/2014 - 03/2014
2Shock
10/2014 - 03/2014
2Necrosis
06/2010 - 09/2006
2Neoplasm Metastasis (Metastasis)
09/2008 - 10/2004
1Unstable Angina
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Amyloid Plaque
11/2021
1Head and Neck Neoplasms (Head and Neck Cancer)
11/2021
1Shoulder Pain
11/2021
1Postpartum Depression (Post-Natal Depression)
01/2021
1Reperfusion Injury
01/2020
1Adenocarcinoma of Lung
07/2019
1Hyperthyroidism
10/2018
1Body Weight (Weight, Body)
05/2018
1Inflammation (Inflammations)
01/2018
1Mycobacterium Infections (Infections, Mycobacterium)
07/2015
1Hypoxia (Hypoxemia)
07/2015
1Synovitis
06/2015

Drug/Important Bio-Agent (IBA)

32Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2008
14Proteins (Proteins, Gene)FDA Link
05/2021 - 10/2004
7Blood Proteins (Serum Proteins)IBA
11/2020 - 10/2011
5Pharmaceutical PreparationsIBA
11/2020 - 01/2010
4MicroRNAs (MicroRNA)IBA
01/2022 - 01/2013
4LipidsIBA
01/2022 - 01/2017
4Messenger RNA (mRNA)IBA
01/2020 - 07/2006
4Biological ProductsIBA
06/2010 - 09/2007
4TrichosanthinIBA
06/2010 - 09/2007
3DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2012
3zhibai dihuangIBA
01/2020 - 01/2018
3cerivastatin (Kazak)FDA Link
02/2015 - 04/2012
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2022 - 07/2015
2Insulin (Novolin)FDA Link
11/2021 - 02/2008
2Complement System Proteins (Complement)IBA
11/2020 - 01/2018
2Therapeutic UsesIBA
01/2020 - 04/2002
2salicylhydroxamic acid (SHAM)IBA
10/2014 - 09/2006
2ParaffinIBA
12/2010 - 03/2009
2GlucocorticoidsIBA
01/2010 - 09/2008
2LipopolysaccharidesIBA
09/2006 - 03/2003
2Carbon Tetrachloride (Tetrachloromethane)IBA
04/2002 - 02/2002
1pyridoxamine phosphateIBA
01/2022
1Pyridoxal Phosphate (Pyridoxal 5 Phosphate)IBA
01/2022
1hydroxide ionIBA
01/2022
1Competitive Endogenous RNAIBA
01/2022
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2021
1Cholesterol Esters (Cholesteryl Esters)IBA
01/2021
1Tuberculin (PPD)IBA
01/2021
1Lipopolysaccharide ReceptorsIBA
11/2020
1Isoniazid (Ftivazide)FDA LinkGeneric
11/2020
1extracellular matrix receptorIBA
11/2020
1Rifampin (Rifampicin)FDA LinkGeneric
11/2020
1MethyltransferasesIBA
01/2020
1salvianolic acid BIBA
01/2020
1Glutamic Acid (Glutamate)FDA Link
11/2019
1XanthineIBA
11/2019
1Glutathione Disulfide (GSSG)FDA LinkGeneric
08/2019
1Arachidonic Acid (Vitamin F)IBA
08/2019
1Histidine (L-Histidine)FDA Link
08/2019
1Cysteine (L-Cysteine)FDA Link
08/2019
1Biliverdine (Biliverdin)IBA
08/2019
1IntegrinsIBA
07/2019
1Triiodothyronine (Liothyronine)FDA LinkGeneric
10/2018
1Serum Amyloid A Protein (Serum Amyloid A)IBA
01/2017
1Vitamin KFDA Link
01/2017
1plasma protein Z (protein Z)IBA
01/2017
1Complement C4b-Binding ProteinIBA
01/2017
1HaptoglobinsIBA
07/2015
1gamma-Glutamyl Hydrolase (Carboxypeptidase G2)IBA
07/2015
1Sodium Hydroxide (Caustic Soda)FDA Link
06/2015
1Trypan BlueFDA Link
06/2015
1Superoxide Dismutase-1IBA
01/2015
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2015
1Small Interfering RNA (siRNA)IBA
10/2014
1RNA Polymerase II (RNA Polymerase B)IBA
10/2014

Therapy/Procedure

10Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2021 - 09/2014
4Therapeutics
01/2018 - 08/2008
2Acupuncture Points (Acupuncture Point)
11/2021 - 11/2021
2Resuscitation
10/2014 - 03/2014
2Lasers (Laser)
09/2014 - 10/2011
2Ligation
03/2014 - 09/2006
1Radiotherapy
11/2021
1Percutaneous Collagen Induction
11/2021
1Electroacupuncture
11/2021
1Subcutaneous Injections
05/2018
1Combination Drug Therapy (Combination Chemotherapy)
11/2016